ABSTRACT
The ocular surface is covered by a tear film consisting of an aqueous/mucin phase and a superficial lipid layer. Mucins, highly O-glycosylated proteins, are responsible for lubrication and ocular surface protection. Due to contact lens wear or eye disorders, lubrication of the ocular surface can be affected. Artificial glycopolymers which mimic natural mucins could be efficient in ophthalmic therapy. Various neutral, positively, and negatively charged mucin-mimicking glycopolymers were synthesized (n = 11), cultured in different concentrations (1%, 0.1%, and 0.01% w/v) with human corneal epithelial cells (HCE), and analyzed by various cytotoxicity/viability, morphology, and immunohistochemistry (IHC) assays. Six of the eleven glycopolymers were selected for further analysis after cytotoxicity/viability assays. We showed that the six selected glycopolymers had no cytotoxic effect on HCE cells in the 0.01% w/v concentration. They did not negatively affect cell viability and displayed both morphology and characteristic markers as untreated control cells. These polymers could be used in the future as mucin-mimicking semi-synthetic materials for lubrication and protection of the ocular surface.
Subject(s)
Epithelial Cells , Mucins , Humans , Eye , FaceABSTRACT
Objectives: To propose a novel clinical classification system of gallbladder cancer, and to investigate the differences of clinicopathological characteristics and prognosis based on patients who underwent radical resection with different types of gallbladder cancer. Methods: The clinical data of 1 059 patients with gallbladder cancer underwent radical resection in 12 institutions in China from January 2013 to December 2017 were retrospectively collected and analyzed.There were 389 males and 670 females, aged (62.0±10.5)years(range:22-88 years).According to the location of tumor and the mode of invasion,the tumors were divided into peritoneal type, hepatic type, hepatic hilum type and mixed type, the surgical procedures were divided into regional radical resection and extended radical resection.The correlation between different types and T stage, N stage, vascular invasion, neural invasion, median survival time and surgical procedures were analyzed.Rates were compared by χ(2) test, survival analysis was carried by Kaplan-Meier and Log-rank test. Results: Regional radical resection was performed in 940 cases,including 81 cases in T1 stage,859 cases in T2-T4 stage,119 cases underwent extended radical resection;R0 resection was achieved in 990 cases(93.5%).The overall median survival time was 28 months.There were 81 patients in Tis-T1 stage and 978 patients in T2-T4 stage.The classification of gallbladder cancer in patients with T2-T4 stage: 345 cases(35.3%)of peritoneal type, 331 cases(33.8%) of hepatic type, 122 cases(12.5%) of hepatic hilum type and 180 cases(18.4%) of mixed type.T stage(χ(2)=288.60,P<0.01),N stage(χ(2)=68.10, P<0.01), vascular invasion(χ(2)=128.70, P<0.01)and neural invasion(χ(2)=54.30, P<0.01)were significantly correlated with the classification.The median survival time of peritoneal type,hepatic type,hepatic hilum type and mixed type was 48 months,21 months,16 months and 11 months,respectively(χ(2)=80.60,P<0.01).There was no significant difference in median survival time between regional radical resection and extended radical resection in the peritoneal type,hepatic type,hepatic hilum type and mixed type(all P>0.05). Conclusion: With application of new clinical classification, different types of gallbladder cancer are proved to be correlated with TNM stage, malignant biological behavior and prognosis, which will facilitate us in preoperative evaluation,surgical planning and prognosis evaluation.
Subject(s)
Gallbladder Neoplasms , Adult , Aged , Aged, 80 and over , China , Female , Humans , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Staging , Pilot Projects , Prognosis , Retrospective Studies , Survival Rate , Young AdultABSTRACT
OBJECTIVES: Ankylosing spondylitis (AS) is a chronic, inflammatory arthritis and autoimmune disease. BACKGROUND: The main symptom of AS is inflammatory spinal pain; with time, some patients develop ankylosis and spinal immobility. We aim to find cure available for ankylosing spondylitis. MATERIALS AND METHODS: We used the GSE11886 series to identify potential genes that related to AS to construct a regulation network. RESULTS: In the network, some of TFs and target genes have been proved related with AS in previous study, such as NFKB1, STAT1, STAT4, TNFSF10, IL2RA, and IL2RB. We also found some new TFs (Franscription Factors) and target genes response to AS, such as BXDC5, and EGFR. Further analysis indicated some significant pathways are associated with AS, including antigen processing and presentation and cytokine-cytokine receptor interaction, etc.; although not significant, there was evident that they play an important role in AS progression, such as apoptosis and systemic lupus erythematosus. CONCLUSIONS: Therefore, it is demonstrated that transcriptome network analysis is useful in identification of the candidate genes in AS.
Subject(s)
Gene Expression Profiling , Spondylitis, Ankylosing/genetics , Case-Control Studies , Databases, Genetic , Gene Expression Profiling/methods , Gene Expression Regulation , Gene Regulatory Networks , Genetic Association Studies , Genetic Markers , Genetic Predisposition to Disease , Humans , Oligonucleotide Array Sequence Analysis , PhenotypeABSTRACT
The present study examined the roles of ventrolateral orbital cortex (VLO) 5-HT1, 5-HT2, 5-HT3, 5-HT4, 5-HT5, 5-HT6 and 5-HT7 receptor subtypes in mediating 5-HT-induced antiallodynic actions in the rat spared nerve injury (SNI) pain model. Changes in paw withdrawal threshold (PWT) were measured using von-Frey filaments. Microinjection of 5-HT (2, 5 and 10µg, in 0.5µl) into the VLO depressed allodynia induced by SNI, and the PWT increased in a dose-dependent manner. Microinjection of selective 5-HT1A, 5-HT2, 5-HT3, 5-HT4, 5-HT5A, 5-HT6 and 5-HT7 receptor antagonists, 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl] piperazine hydrobromide (NAN-190) (10µg), cyproheptadine (50ng), granisetron hydrochloride (granisetron) (10µg), 1-[2-[(methylsulfonyl)-amino]ethyl]-4-piperidinyl]methyl1-methyl-1H-indole-3-carboxylate (GR113808) (5µg), SB699551 dihydrochloride (SB699551) (10µg), SB258585 dihydrochloride (SB258585) (2µg) or SB269970 hydrochloride (SB269970) (10µg) into the VLO 5-min prior to 5-HT (10µg) injection, all antagonized the 5-HT-induced inhibition of allodynia. In addition, these antagonists applied alone to VLO did not influence allodynia. These results suggest that although 5-HT1-7 receptor subtypes in the VLO do not have a tonic modulatory action on the allodynia induced by SNI, they are involved in mediating the depression of the SNI allodynia produced by injection of 5HT into VLO.
Subject(s)
Frontal Lobe/drug effects , Hyperalgesia/metabolism , Pain Threshold/drug effects , Receptors, Serotonin/metabolism , Serotonin Antagonists/pharmacology , Serotonin/pharmacology , Animals , Frontal Lobe/metabolism , Male , Neuralgia/metabolism , Pain Measurement , Rats , Rats, Sprague-DawleyABSTRACT
Recent study from our laboratory has indicated that microinjection of glutamate into the nucleus tractus solitarius (NTS) facilitates the cardiac-somatic reflex induced by pericardial capsaicin. Further, N-methyl-d-aspartate (NMDA) receptors and metabotropic glutamate receptors (mGluRs) mediate this function. However, the roles of the individual receptor subtypes or subunits in modulating cardiac nociception are unknown. Among the three groups of mGluRs, group III mGluRs are the primary mGluR subtype expressed in visceral afferent neurons in the NTS. The present study examined the roles of group III mGluRs and their subtype 7 and 8 receptors (mGluR7 and mGluR8) in modulating the cardiac-somatic reflex induced by pericardial capsaicin, which was monitored by recording electromyogram (EMG) activity from the spinotrapezius muscle in anesthetized rats. Intra-NTS microinjection of a group III mGluR agonist, l-(+)-2-Amino-4-phosphonobutyric acid (l-AP4, at 1, 10, and 20 nmol) or a selective mGluR7 agonist, N,N'-diphenylmethyl-1,2-ethanediamine dihydrochloride (AMN082, at 1, 2, and 4 nmol) both decreased the EMG response in a dose-dependent manner. This decrease was inhibited by the group III mGluR antagonist (RS)-α-Methylserine-O-phosphate (MSOP, at 20 nmol). In contrast, intra-NTS microinjection of a selective mGluR8 agonist, (S)-3, 4-dicarboxyphenylglycine (DCPG, at 6 and 8 nmol), significantly increased the EMG response above control levels. This effect was eliminated by intra-NTS MSOP and by vagal deafferentation. These data suggest that group III mGluRs and mGluR7 in the NTS display an inhibitory effect, while mGluR8 displays a facilitatory effect in modulating cardiac nociception, and this facilitatory effect is dependent on vagal afferents.
Subject(s)
Heart/innervation , Nociception/physiology , Pain, Referred/metabolism , Receptors, Metabotropic Glutamate/metabolism , Solitary Nucleus/metabolism , Afferent Pathways/physiology , Animals , Male , Rats , Rats, Sprague-Dawley , Thorax , Vagus Nerve/physiologyABSTRACT
Many patients suffer from secondary muscle hyperalgesia after experiencing angina pectoris. In this study, we examined the role of the nucleus tractus solitarius (NTS) and glutamate receptors in modulating cardiac-evoked muscle hyperalgesia induced by pericardial capsaicin, which was monitored by recording electromyogram (EMG) activity from the spinotrapezius muscle in the anesthetized rat. Unilateral chemical lesioning of the commissural NTS with the neurotoxin ibotenic acid significantly depressed the cardiac-somatic reflex; the EMG responses decreased to 56.4 ± 6.9% of that of the controls (5 of 5). Microinjection of the excitatory amino acid glutamate, at 10, 20, and 50 nmol, into the commissural NTS increased the EMG response, in a dose-dependent manner, to 116.9 ± 4.9%, 143.9 ± 10.2%, and 214.2 ± 15.8% (n=8), respectively, of that of the controls. In contrast, microinjection of the N-methyl-D-aspartate (NMDA) receptor antagonist (+)-5-methyl-10, 11-dihydro-5H-dibenzo [a, d]-cyclohepten-5,10-imine maleate (MK-801) at 4 and 6 nmol, decreased the EMG response to 45.2 ± 10.6% and 36.8 ± 14.3%, respectively, of that of the controls (n=8 for each dose). Similarly, the metabotropic glutamate receptor (mGluR) antagonist (RS)-a-methyl-4-carboxyphenylglycine (MCPG), at 2.5 and 5 nmol, decreased the EMG response to 65.2 ± 16.3% and 57.0 ± 4.2%, respectively, of that of the controls. When a combination of MK-801 and MCPG was administrated, the EMG response further decreased to 22.5 ± 13.2% (n=6) of that of the controls. However, administration of a non-NMDA receptor antagonist 6, 7-dinitroquinoxaline-2, 3-dione (DNQX), at 2 and 5 nmol, had no effect on the EMG response. These results suggest that the NTS is involved in the facilitation of the cardiac-somatic reflex, and that the NMDA receptor and mGluRs play an important role in mediating this effect.
Subject(s)
Cardiovascular Physiological Phenomena , Glutamic Acid/physiology , Hyperalgesia/physiopathology , Receptors, Glutamate/physiology , Reflex/physiology , Solitary Nucleus/physiology , Animals , Denervation/methods , Glutamic Acid/toxicity , Hyperalgesia/chemically induced , Male , Microinjections/methods , Neurotoxins/toxicity , Rats , Rats, Sprague-Dawley , Solitary Nucleus/drug effectsABSTRACT
Eight phenolic compounds, including (-)-epicatechin (1) and seven proanthocyanidins (2-8), were obtained from the butanol extract of Parabarium huaitingii (PHB). Their chemical structures were identified based on analyses of mass spectra (MS), NMR, CD spectra, and partial acid catalyzed thiolytic degradation. The observation made by laser scanning confocal microscope found a significant increase of the concentration of intracellular Ca²+ ([Ca²+](i)) in single myocytes when the PHB was added, while compounds 1 and 3 had the same physiological effect. Further investigations showed PHB had a dose-dependent positive inotropic effect on isolated right atria and papillary muscle of left ventricle of the rat, while having no significant influence on the spontaneous beating rate of the isolated right atria. The inotropic effect of PHB could be greatly abolished by pretreating the myocardium in Ca²+-free solution. These findings indicated that PHB could significantly increase [Ca²+](i) in myocytes, which was greatly dependent on the influx of extracellular Ca²+. Compounds 1 and 3 might be the effective ingredients of the inotropic effect of PHB. In addition, PHB could also significantly decrease the infarct size of the heart on acute myocardial infarction (AMI) model rats, which suggested its myocardial protective effect on ischemic myocardium. The positive inotropic effect of PHB, together with its myocardial protective effect on AMI, suggested that PHB had a promising potential for the prevention and treatment of heart failure, especially the one that was caused by AMI.
Subject(s)
Apocynaceae/chemistry , Cardiotonic Agents/pharmacology , Catechin/pharmacology , Myocardial Contraction/drug effects , Myocardial Infarction/prevention & control , Proanthocyanidins/pharmacology , Animals , Calcium/metabolism , Cardiotonic Agents/chemistry , Catechin/chemistry , Disease Models, Animal , Dose-Response Relationship, Drug , Heart/drug effects , Medicine, Chinese Traditional , Plant Extracts/chemistry , Plant Stems/chemistry , Plants, Medicinal/chemistry , Proanthocyanidins/chemistry , Prohibitins , Random Allocation , Rats , Rats, Wistar , Stimulation, ChemicalABSTRACT
The purpose of the present study was to examine whether the rostroventral portion of the medulla oblongata (RVM) exerts descending modulation on the cardiosomatic motor reflex (CMR) in rats. Capsaicin (1 µg/ml, 0.2 ml) was injected into the pericardial sac as an algesic substance to induce the CMR, which was monitored via electromyogram (EMG) responses of dorsal spinotrapezius muscle to the noxious cardiac stimulus. Descending modulation of the CMR was observed by electrical or chemical stimulation of RVM. Specifically, electrical stimulation of RVM produced facilitatory, inhibitory or biphasic effects on the CMR evoked by noxious cardiac stimulation, depending on stimulation intensity. In addition, glutamate receptor activation in RVM replicated the effects of electrical stimulation. Lidocaine interruption of the ventrolateral funiculus/ventral funiculus (VLF/VF) or transection of the dorsolateral funiculus (DLF) revealed that the descending facilitatory and inhibitory influences from RVM were conveyed via the VLF/VF and DLF, respectively. Furthermore, intrathecal administration of naloxone or yohimbine partly reversed the inhibitory effect of RVM electrical stimulation, suggesting that opioid and noradrenergic systems are involved in descending RVM modulation of the CMR.
Subject(s)
Evoked Potentials, Motor/physiology , Medulla Oblongata/physiology , Reflex/physiology , Adrenergic alpha-2 Receptor Antagonists/pharmacology , Anesthetics, Local/pharmacology , Animals , Capsaicin/pharmacology , Dose-Response Relationship, Drug , Electric Stimulation/methods , Electromyography , Evoked Potentials, Motor/drug effects , Functional Laterality/drug effects , Lidocaine/pharmacology , Male , Medulla Oblongata/drug effects , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Neural Pathways/drug effects , Neural Pathways/physiology , Rats , Rats, Sprague-Dawley , Reflex/drug effects , Sensory System Agents/pharmacology , Spinal Cord Injuries/pathology , Yohimbine/pharmacologyABSTRACT
The present study examined the role of dopamine and D(1)-and D(2)-like dopamine receptors in ventrolateral orbital cortex (VLO)-evoked anti-hypersensitivity in a rat model of neuropathic pain, as well as the possible underlying mechanisms. Results showed that microinjection of apomorphine [(R(-)-apomorphine hydrochloride)], a non-selective dopamine receptor agonist, into the VLO attenuated spared nerve injury (SNI)-induced mechanical allodynia in a dose-dependent manner. This effect was completely blocked by the D(2)-like dopamine receptor antagonist S(-)-raclopride(+)-tartrate salt (1.5 microg), but was enhanced by the D(1)-like dopamine receptor antagonist SCH23390 (R(+)-SCH-23390 hydrochloride, 5.0 microg). The attenuating effect of apomorphine on mechanical allodynia was mimicked by application of the D(2)-like dopamine receptor agonist quinpirole [((-)-quinpirole hydrochloride, 0.5, 1.0, and 2.0 microg)]. In addition, microinjection of larger doses (10 and 20 microg) of SCH23390 into the VLO significantly attenuated allodynia. Furthermore, microinjections of GABA(A) receptor antagonists, bicuculline [(+)-bicuculline,(S), 9(R)] and picrotoxin (200 and 300 ng for both drugs), into the VLO attenuated mechanical allodynia. A small dose of bicuculline or picrotoxin (100 ng) resulted in increased quinpirole (0.5 microg)-induced anti-allodynia. In contrast, GABA(A) receptor agonists, muscimol hydrochloride (250 ng) or THIP [(2,5,6,7-retrahydroisoxazolo(5,4-c)pyridine-3-ol hydrochloride, 1.0 microg)], blocked quinpirole (2.0 microg)-induced attenuation. These results suggest that the dopaminergic system is involved in mediating VLO-induced anti-hypersensitivity, activation of D(2)-like dopamine receptors, and inhibition of D(1)-like receptors resulting in anti-hypersensitivity. In addition, the mechanisms of GABAergic disinhibition might be involved in D(2)-like receptor mediating effects in neuropathic pain.
Subject(s)
Dopamine/metabolism , Nociceptors/metabolism , Peripheral Nervous System Diseases/metabolism , Prefrontal Cortex/metabolism , Receptors, Dopamine/physiology , Animals , Disease Models, Animal , Male , Peripheral Nervous System Diseases/pathology , Peripheral Nervous System Diseases/physiopathology , Prefrontal Cortex/anatomy & histology , Rats , Rats, Sprague-DawleyABSTRACT
We analyzed the obesity trends in Hong Kong using data from a health assessment program. We recruited 84 357 subjects (27 452 men and 56 905 women; age: mean+/-s.d. 49.0+/-14.7 years, range 20-98 years) in three phases: (1) April 1996 to August 1997 (n=17 119); (2) February 2001 to December 2002 (n=16 978); and (3) January 2004 to December 2005 (n=50 260). Waist circumferences were available only in phases 2 and 3. Central obesity was defined as waist > or =90 cm in men and > or =80 cm in women. Overweight and obesity (general) were defined as body mass index (BMI) > or =23 and > or =25 kg/m(2), respectively. The age-standardized rate (95% CI) of general obesity was stable in men (31.6% (29.6, 33.7) in 1996 vs 31.0% (30.0, 32.0) in 2005, P: NS) but declined in women (22.4% (21.3, 23.5) in 1996 vs 18.8% (18.2, 19.4) in 2005, P<0.05). The prevalence of central obesity increased from 23.0% (20.6, 25.4) in 2001 to 26.9% (26.0, 27.8) in 2005 in men (P<0.05) and remained stable in women, with corresponding rates of 27.5% (25.8, 29.3) and 26.6% (26.0, 27.3), respectively (P: NS). In summary, despite stable or declining BMI, age-standardized central obesity failed to decline in Hong Kong Chinese women and continued to increase in Chinese men over a 10-year period.
Subject(s)
Body Mass Index , Obesity, Abdominal/epidemiology , Obesity/epidemiology , Adult , Aged , Female , Hong Kong/epidemiology , Humans , Male , Middle Aged , Prevalence , Sex Factors , Waist CircumferenceABSTRACT
Previous studies have indicated that mu-opioid receptors in the thalamic nucleus submedius (Sm) are involved in descending antinociception in behavioral tests. The present study examined the effect of mu-opioid receptor activation in the Sm upon bee venom-evoked c-Fos expression in the spinal dorsal horn associated with flinching behavior, and determined whether the ATP-sensitive potassium channel (K-ATP channel) was involved in this effect in a rat model. A dilute bee venom solution, subcutaneously injected unilaterally into a rat hind paw pad, induced significant c-Fos expression in the lumbar spinal dorsal horn, which is associated with paw flinching behavior. This effect was depressed by microinjection of the mu-opioid receptor agonist [d-Ala2, N-MePhe4, Gly-ol5]-enkephalin (DAMGO) into the Sm, which was antagonized by pre-treatment with mu-receptor antagonist beta-funaltrexamine at the same Sm site. Further studies found that glibenclamide, a K-ATP channel inhibitor, also blocked DAMGO-induced inhibition. These results provide functional anatomic support for the involvement of Sm and mu-opioid receptors in the modulation of persistent inflammatory nociception, and suggest that these effects were produced by opening K-ATP channel and inhibiting neuronal activity. Together with previous studies, the inhibition of the neuronal activity induced by mu-opioid receptor activation may activate descending antinociceptive pathways through a GABAergic disinhibitory mechanism and depress the nociceptive information transmission at the level of the spinal cord.
Subject(s)
Bee Venoms/pharmacology , Behavior, Animal/drug effects , Proto-Oncogene Proteins c-fos/biosynthesis , Receptors, Opioid, mu/physiology , Spinal Cord/drug effects , Thalamic Nuclei/drug effects , Animals , Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology , Male , Pain Measurement , Rats , Rats, Sprague-Dawley , Receptors, Opioid, mu/agonists , Spinal Cord/metabolism , Thalamic Nuclei/physiologyABSTRACT
The present study examined the involvement of 5-HT in the ventrolateral orbital cortex (VLO) on descending antinociception and determined which subtypes of 5-HT receptors mediated this effect. This study focused on the effects of 5-HT microinjection in the VLO of lightly anesthetized male rats on the radiant heat-evoked tail flick (TF) reflex, as well as the influence of 5-HT(1A), 5-HT(2), 5-HT(3), and 5-HT(4) receptor subtype antagonists on the effect of 5-HT. Results showed that 5-HT microinjection (2, 5, 10 microg, in 0.5 microl) into the VLO depressed the TF reflex in a dose-dependent manner. Pretreatment with 5-HT receptor antagonists (1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl] piperazine hydrobromide (NAN-190), cyproheptadine hydrochloride (CPT) and 1-methyl-N-(8-methyl-8-azabicyclo[3.2.3]-oct-3-yl)-1H-indazole-3-carboxamide maleate salt (LY-278,584)), specific for 5-HT(1A), 5-HT(2) and 5-HT(3) receptors, respectively, partially reversed the 5-HT-evoked inhibition. In contrast, the 5-HT(4) receptor antagonist, 1-[2-[(methylsulfonyl)-amino]ethyl]-4-piperidinyl]methyl1-methyl-1H-indole-3-carboxylate (GR 113808), had no effect on the inhibition of 5-HT. Microinjections of NAN-190, CPT and LY-278,584 alone into the VLO had no effect on the TF reflex. These results suggest that 5-HT(1A), 5-HT(2) and 5-HT(3), but not 5-HT(4) receptors, are involved in mediating 5-HT-induced antinociception in the VLO. According to different properties and distribution patterns of the 5-HT receptor subtypes on neurons, the possible mechanism of 5-HT activation of the VLO-periaqueductal gray (PAG) descending antinociceptive pathway is discussed.
Subject(s)
Frontal Lobe/drug effects , Nociceptors/physiology , Pain Threshold/drug effects , Receptors, Serotonin/classification , Receptors, Serotonin/physiology , Serotonin/pharmacology , Animals , Area Under Curve , Behavior, Animal , Dose-Response Relationship, Drug , Drug Interactions , Male , Microinjections/methods , Pain Measurement/methods , Rats , Rats, Sprague-Dawley , Reflex/drug effects , Serotonin Antagonists/administration & dosage , Tail/physiology , Time FactorsABSTRACT
In the present study, the effect of chronic fatigue stress on the neuronal nitric oxide synthase (nNOS) in the rat nucleus accumbens (NAc) was assessed in order to explore the neurobiology mechanism of central fatigue stress, especially the role of the NAc in central fatigue. In the experiment, adult male Wistar rats were forced to swim till exhaustion every day for 4 weeks. Immunohistochemistry was used for measurement of the nNOS-positive neurons associated with the image manipulation. Our results showed that a long-time exposure to chronic forced swim stress increased the number of nNOS immunoreactive-positive neurons in the rat NAc (106.7%, P<0.001), distributed area (150.2%, P<0.001) and gray degree value (11.3%, P<0.01). The results indicate that nitric oxide (NO)/nNOS may be involved in the formation of the fatigue stress, and that NO may play a role in the regulation of stress in the NAc. The up-regulation of NO/nNOS during the exposure to long-time swim stress is likely to be one of the results of brain damage and psychiatric disorder induced by NO overproduction.
Subject(s)
Fatigue/physiopathology , Nitric Oxide Synthase/metabolism , Nucleus Accumbens/enzymology , Up-Regulation/physiology , Animals , Chronic Disease , Fatigue/enzymology , Physical Conditioning, Animal , Physical Exertion , Rats , Rats, WistarABSTRACT
INTRODUCTION: With recognition of the important role of central obesity in metabolic syndrome (MES), the International Diabetes Federation (IDF) has proposed a revised definition for MES in early 2005. Information of MES in Chinese by IDF criteria is limited. METHODS: This was a cross-sectional observation survey. A sample of 7,473 subjects (2,660 men and 4,813 women) was examined. They presented voluntarily in the period between August 2001 and September 2002 for health assessment at the three health centres of the United Christian Nethersole Community Health Service. RESULTS: The mean age and standard deviation was 50.4 +/- 10.6 years (range 19-93 years, median 48.0 years). Among them, 30 percent had central obesity, 34 percent had low high-density lipoprotein cholesterol, 20 percent had hypertriglyceridaemia, 47 percent had high blood pressure, and 23 percent had dysglycaemia. The age-standardised percentages of MES by National Cholesterol Education Programme and IDF criteria were 18.3 and 13.9 percent, respectively. CONCLUSION: MES is not uncommon among the Hong Kong Chinese community. Further studies on the management and prevention of MES are indicated.
Subject(s)
Community Health Services/standards , Metabolic Syndrome/epidemiology , Obesity/epidemiology , Primary Health Care/organization & administration , Adult , Age Distribution , Aged , Aged, 80 and over , Chi-Square Distribution , Cross-Sectional Studies , Female , Health Surveys , Hong Kong/epidemiology , Humans , Male , Metabolic Syndrome/prevention & control , Metabolic Syndrome/therapy , Middle Aged , Obesity/prevention & control , Obesity/therapy , Prevalence , Primary Prevention/organization & administration , Probability , Program Development , Program Evaluation , Risk Assessment , Severity of Illness Index , Sex DistributionABSTRACT
Previous studies have demonstrated that opioid receptors in the prefrontal ventrolateral orbital cortex (VLO) are involved in anti-nociception. The aim of this current study was to examine whether opioid receptors in the VLO have effects on the hypersensitivity induced by contralateral L5 and L6 spinal nerve ligation (SNL), termed as mirror neuropathic pain (MNP) in the male rat. Morphine (1.0, 2.5, 5.0 microg) microinjected into the VLO contralateral to the SNL depressed the mechanical paw withdrawal assessed by von Frey filaments and the cold plate (4 degrees C)-induced paw lifting in a dose-dependent manner on the side without SNL. These effects were antagonized by microinjection of the non-selective opioid receptor antagonist naloxone (1.0 mug) into the same VLO site. Microinjection of endomorphin-1 (5.0 microg), a highly selective mu-opioid receptor agonist, and [d-Ala(2), d-Leu(5)]-enkephalin (DADLE, 10 microg), a delta-/mu-receptor agonist, also depressed the MNP. The effects of both drugs were blocked by selective mu-receptor antagonist beta-funaltrexamine (beta-FNA, 3.75 microg), but the effect of the DADLE was not influenced by the selective delta-receptor antagonist naltrindole (5.0 microg). Microinjection of the kappa-opioid receptor agonist spiradoline mesylate salt (U-62066) (100 microg) had no effect on the MNP. These results suggest that the VLO is involved in opioid-induced inhibition of the MNP and the effect is mediated by mu- (but not delta- and kappa-) opioid receptors.
Subject(s)
Analgesics, Opioid/pharmacology , Peripheral Nervous System Diseases/drug therapy , Peripheral Nervous System Diseases/metabolism , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Receptors, Opioid, mu/metabolism , Afferent Pathways/drug effects , Afferent Pathways/metabolism , Animals , Functional Laterality , Hyperalgesia/drug therapy , Hyperalgesia/metabolism , Hyperalgesia/physiopathology , Ligation , Male , Morphine/pharmacology , Narcotic Antagonists/pharmacology , Nociceptors/drug effects , Nociceptors/metabolism , Pain Measurement , Pain Threshold/drug effects , Pain Threshold/physiology , Peripheral Nervous System Diseases/physiopathology , Rats , Rats, Sprague-Dawley , Receptors, Opioid, delta/agonists , Receptors, Opioid, delta/antagonists & inhibitors , Receptors, Opioid, delta/metabolism , Receptors, Opioid, kappa/agonists , Receptors, Opioid, kappa/antagonists & inhibitors , Receptors, Opioid, kappa/metabolism , Receptors, Opioid, mu/agonists , Receptors, Opioid, mu/antagonists & inhibitors , Spinal Nerves/injuries , Spinal Nerves/physiopathologyABSTRACT
Previous studies have indicated that thalamic nucleus submedius is involved in opioid-mediated antinociception in tail flick test and formalin test. The current study examined the effects of opioids microinjected into the thalamic nucleus submedius on the allodynia developed in neuropathic pain model rats, and determined the roles of different subtypes of opioid receptors in the thalamic nucleus submedius opioid-evoked antiallodynia. The allodynic behaviors induced by L5/L6 spinal nerve ligation were assessed by mechanical (von Frey filaments) and cold (4 degrees C plate) stimuli. Morphine (1.0, 2.5, and 5.0 microg) microinjected into the thalamic nucleus submedius contralateral to the nerve injury paw produced a dose-dependent inhibition of the mechanical and cold allodynia, and these effects were reversed by microinjection of the non-selective opioid receptor antagonist naloxone (1.0 microg) into the same site. Microinjection of endomorphin-1 (5.0 microg), a highly selective mu-opioid receptor agonist, and [D-Ala2, D-Leu5]-enkephalin (10 microg), a delta-/mu-opioid receptor agonist, also inhibited the allodynic behaviors, and these effects were blocked by selective mu-opioid receptor antagonist beta-funaltrexamine hydrochloride (3.75 microg). However, the [D-Ala2, D-Leu5]-enkephalin-evoked antiallodynic effects were not influenced by the selective delta-opioid receptor antagonist naltrindole (5.0 microg). Microinjection of the selective kappa-receptor agonist spiradoline mesylate salt (100 microg) into the thalamic nucleus submedius failed to alter the allodynia induced by spinal nerve ligation. These results suggest that the thalamic nucleus submedius is involved in opioid-evoked antiallodynia which is mediated by mu- but not delta- and kappa-opioid receptor in the neuropathic pain model rats.
Subject(s)
Analgesics, Opioid/pharmacology , Neuralgia/metabolism , Pain Threshold/physiology , Peripheral Nervous System Diseases/metabolism , Receptors, Opioid/metabolism , Thalamus/metabolism , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Interactions/physiology , Hyperalgesia/drug therapy , Hyperalgesia/metabolism , Hyperalgesia/physiopathology , Male , Morphine/pharmacology , Narcotic Antagonists/pharmacology , Neural Pathways/physiology , Neuralgia/drug therapy , Neuralgia/physiopathology , Pain Measurement , Pain Threshold/drug effects , Peripheral Nervous System Diseases/drug therapy , Peripheral Nervous System Diseases/physiopathology , Physical Stimulation , Prefrontal Cortex/physiology , Rats , Rats, Sprague-Dawley , Receptors, Opioid/agonists , Receptors, Opioid, kappa/agonists , Receptors, Opioid, kappa/metabolism , Receptors, Opioid, mu/agonists , Receptors, Opioid, mu/antagonists & inhibitors , Receptors, Opioid, mu/metabolism , Receptors, sigma/agonists , Receptors, sigma/metabolism , Thalamus/anatomy & histology , Thalamus/drug effectsABSTRACT
GABAergic projection from thalamic reticular nucleus to thalamic nucleus submedius in the medial thalamus of the rat was studied by using immunohistochemistry for GABA, retrograde labeling with Fluoro-Gold combined with immunohistochemistry for GABA, and anterograde labeling with biotinylated dextranamine. Immunohistochemistry displayed that only GABA immunoreactive terminals were observed in the thalamic nucleus submedius, while GABA immunoreactive neuronal cell bodies were located in the thalamic reticular nucleus and lateral geniculate nucleus. Injection of Fluoro-Gold into the thalamic nucleus submedius resulted in massive retrogradely labeled neuronal cell bodies in the rostroventral portion of the ipsilateral thalamic reticular nucleus and a few in the contralateral thalamic reticular nucleus, and most of these cell bodies showed GABA immunopositive staining. Many biotinylated dextranamine anterogradely labeled fibers and terminals in the thalamic nucleus submedius were observed after injection of biotinylated dextranamine into the thalamic reticular nucleus. The present results provide a morphological evidence for a hypothesis that a disinhibitory effect on output neurons elicited by opioid or 5-hydroxytryptamine inhibiting a GABAergic terminal in the thalamic nucleus submedius may lead to activation of the descending inhibitory system and depression of the nociceptive inputs at the spinal cord level.
Subject(s)
Intralaminar Thalamic Nuclei/physiology , Mediodorsal Thalamic Nucleus/physiology , Neurons/physiology , gamma-Aminobutyric Acid/physiology , Animals , Axonal Transport , Male , Nerve Endings/physiology , Neural Pathways/physiology , Rats , Rats, Sprague-DawleyABSTRACT
The present study was designed to investigate the roles of different subtypes of opioid receptors in ventrolateral orbital cortex (VLO) opioid-evoked antinociception in formalin test by using an automatic detection system for recording the nociceptive behavior (agitation) and a manual method for detecting the duration of licking the injected paw in the conscious rat. Formalin (5%, 50 microl) s.c. injected into the hindpaw produced a biphasic agitation response or lengthening duration of licking. Morphine (5 microg) microinjected unilaterally into VLO significantly inhibited the agitation response and the licking time, and these effects were blocked by pre-administration of the non-selective opioid receptor antagonist naloxone (1.0 microg) into the same site. Microinjection of endomorphin-1 (5 microg), a selective micro-receptor agonist, and [D-Ala2, D-Leu5]-enkephalin (DADLE, 10 microg), a delta-/micro-receptor agonist also inhibited the nociceptive behaviors, and both the effects were blocked by selective mu-receptor antagonist beta-funaltrexamine hydrochloride (beta-FNA; 3.75 microg), but the DADLE-evoked inhibition was not influenced by the selective delta-receptor antagonist naltrindole (5 microg). Microinjection of selective kappa-receptor agonist (+/-)-trans-U-50488 methanesulfonate salt (1.5 microg) failed to alter the nociceptive behaviors induced by formalin injection. The beta-FNA and naloxone applied into VLO and morphine into the adjacent regions ventral and dorsal to VLO had no effect on the formalin-evoked nociceptive behaviors. These results suggest that mu- but not delta- or kappa-opioid receptor is involved in the VLO opioid-evoked antinociception in formalin test rat.
Subject(s)
Narcotics/administration & dosage , Nociceptors/physiology , Pain/physiopathology , Prefrontal Cortex/metabolism , Receptors, Opioid/metabolism , Animals , Enkephalin, Leucine-2-Alanine/administration & dosage , Injections, Intraventricular , Male , Narcotic Antagonists/administration & dosage , Nociceptors/drug effects , Pain/chemically induced , Pain Measurement , Prefrontal Cortex/drug effects , Rats , Rats, Sprague-Dawley , Receptors, Opioid/drug effectsABSTRACT
A series of reduced benzo[j]fluoranthen-3-ones (1-4) was isolated from fermentations of a fungal strain CBUK20700 (CBS 100220), classified as Cladosporium cf. cladosporioides, during a microbial extract screening programme to identify inhibitors of anti-CD28-induced interleukin-2 (IL-2) production by Jurkat E6-1 cells as potential immunosuppressive agents. These compounds were also found to be tyrosine kinase inhibitors. The structures of compounds 1-4 were elucidated by spectroscopic methods including the HMQC, HMBC and NOESY NMR experiments. The most potent compound in the series, (6bS,7R,8S)-7-methoxy-4,8,9-trihydroxy-1,6b,7,8-tetrahydro-2H-benzo[j]fluoranthen-3-one (1) inhibited anti-CD28-induced IL-2 production and Abl tyrosine kinase with IC50 values of 400 and 60 nM respectively. The 6b-stereoisomeric 2 was a moderate inhibitor of both IL-2 production and Abl tyrosine kinase while the 8-oxo derivative 3 was inactive in both assays. The 8-O-methyl ether 4 was a moderate inhibitor of IL-2 production but exhibited potent inhibition of Abl tyrosine kinase with an IC50 of 45 nM.
Subject(s)
Cladosporium/chemistry , Enzyme Inhibitors/isolation & purification , Fluorenes/isolation & purification , Immunosuppressive Agents/isolation & purification , Interleukin-2/biosynthesis , Protein-Tyrosine Kinases/antagonists & inhibitors , Antibodies/pharmacology , CD28 Antigens/immunology , Cells, Cultured , Cladosporium/classification , Cladosporium/metabolism , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Fermentation , Fluorenes/chemistry , Fluorenes/pharmacology , Humans , Immunosuppressive Agents/chemistry , Immunosuppressive Agents/pharmacology , Inhibitory Concentration 50 , Interleukin-2/antagonists & inhibitors , Jurkat Cells/drug effects , Jurkat Cells/metabolism , Magnetic Resonance Spectroscopy , Mass Spectrometry , Protein-Tyrosine Kinases/metabolism , ThailandABSTRACT
Our previous findings have indicated that the ventrolateral orbital cortex (VLO) may be involved in modulation of nociception and plays an important role as a higher center of an endogenous analgesic system (a feedback loop) consisting of spinal cord-nucleus submedius (Sm)-VLO-periaqueductal gray (PAG)-spinal cord. To further investigate the neurotransmitter mechanism involved in this nociceptive modulatory pathway, we tested the effects of microinjection of morphine (5 microg, 0.5 microl) into VLO on the tail flick (TF) reflex. The results show that a unilateral microinjection of morphine into VLO dose-dependently suppresses the TF reflex. Furthermore, 6 min after termination of morphine injection, microinjection of opioid receptor antagonist naloxone (1.5 microg, 0.5 microl) into the same VLO site reverses this morphine-evoked inhibition of TF reflex. These results suggest that morphine application to the VLO may directly or indirectly activate VLO neurons projecting to the PAG through the opioid receptor mediation leading to activation of the brainstem descending inhibitory system and depression of the nociceptive inputs at the spinal cord level.